2013 Fiscal Year Final Research Report
Development of new therapy targeting HSP27 in colorectal cancer
Project/Area Number |
23591970
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Keio University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Keywords | Heat shock protein 27 / Colorectal cancer / Biomarker / Drug sensitivity |
Research Abstract |
High levels of heat shock protein 27 (HSP27) expression in colon cancer cell lines were associated with low 5-fluorouracil (5-FU) sensitivity. The suppression of HSP27 expression promoted 5-FU sensitivity in colon cancer cell lines in vitro and in vivo. Furthermore, the inhibition of HSP27 phosphorylation by a selective inhibitor promotes 5-FU sensitivity in colorectal cancer cell lines. Similarly, CPT-11 and l-OHP sensitivities were also associated with the expression levels of HSP27. Anti-EGF-R antibody drugs promoted CPT-11 sensitivity by suppressing the expression and the phosphorylation of HSP27. In an adjuvant chemotherapy group who underwent curative resection of colorectal cancer, the cases with low expression of HSP27 had better rate of relapse free survival than those with high expression of HSP27. In conclusion, HSP27 may be a biomarker for sensitivity of anti-cancer drugs and new treatment in colorectal cancer.
|
-
-
-
-
-
[Presentation] 大腸癌における5-fluorouracil感受性の規定因子としてのHeat shock protein 27について, Heat shock protein 27 as a regulator of 5-fluorouracil sensitivity in colorectal cancer cells2011
Author(s)
松永篤志,石井良幸,長谷川博俊,遠藤高志,落合大樹,星野大樹,星野好則,茂田浩平,瀬尾雄樹,星野剛,北川雄光
Organizer
第70回日本癌学会学術総会
Place of Presentation
名古屋
Year and Date
2011-10-05